Laster S F, Martin J L, Fleming J B
J Am Optom Assoc. 1996 Nov;67(11):654-8.
This study was performed to investigate the use of an electronic medication alarm device (Prescript TimeCap) to enhance compliance in glaucoma patients taking pilocarpine.
Thirteen subjects were selected who had been diagnosed with open-angle glaucoma and were receiving 1 drop of pilocarpine solution 4 times a day in both eyes. For each subject, the study was divided into 2 30-day phases, one with the medication alarm device and the other without. Thus, each subject served as his or her own control. Compliance was measured based on the amount of pilocarpine used and by patient questionnaire. In addition, the subjects completed a post-study questionnaire regarding the ease of use of the TimeCap and whether it helped them remember to take their medication.
When subjects used the TimeCap, they administered an average of 2.867 g (P < 0.0001) more pilocarpine over the 30 days than during the period without it. Subjects also estimated a significant difference in compliance level, 95.8 percent with the alarm device versus 83.1 percent without it (p < 0.01). All subjects reported no difficulty using the TimeCap, and all reported that it helped them remember to take their medication.
These results are highly suggestive that the TimeCap is an effective compliance aid for glaucoma patients on pilocarpine.
本研究旨在调查使用电子药物警报装置(Prescript TimeCap)来提高青光眼患者使用毛果芸香碱的依从性。
选取13名被诊断为开角型青光眼且每天双眼各滴1次毛果芸香碱溶液4次的受试者。对于每名受试者,研究分为两个30天阶段,一个阶段使用药物警报装置,另一个阶段不使用。因此,每名受试者自身作为对照。根据毛果芸香碱的使用量和患者问卷来衡量依从性。此外,受试者完成一份关于TimeCap使用便利性以及它是否帮助他们记住服药的研究后问卷。
当受试者使用TimeCap时,他们在30天内使用的毛果芸香碱平均比不使用该装置的时期多2.867克(P < 0.0001)。受试者还估计依从性水平有显著差异,使用警报装置时为95.8%,不使用时为83.1%(p < 0.01)。所有受试者报告使用TimeCap没有困难,并且所有受试者都报告它帮助他们记住服药。
这些结果强烈表明TimeCap对使用毛果芸香碱的青光眼患者是一种有效的依从性辅助工具。